Navigation Links
PIP in Biological Technology

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Admini...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...

PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase I...

PharmAthene Announces $5.5 Million Public Equity Offering

... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting

...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...

PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008

... ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)

...ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced results from a pilot study showing...

PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases

...acea Biotec to Make a $13.1 Million Strategic Investment in PharmAthene ANNAPOLIS, Md., Sept. 30 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has entered into a strateg...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

... ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of All...

PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008

... ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two ...

PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008

... ANNAPOLIS, Md., Sept. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and...

PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration

... ANNAPOLIS, Md., Sept. 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, annou...

PharmAthene Reports Second Quarter 2008 Financial and Operational Results

... On Track to Reach Significant Milestones in Second Half 2008 ANNAPOLIS, Md., Aug. 12 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene

...ies for the Company's Medical Countermeasures ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that Lord Lewis Moonie has joined ...

PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel

...ANNAPOLIS, Md., July 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercializatio...sion into broader markets." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports First Quarter 2008 Financial Results

... ANNAPOLIS, Md., May 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica..., or until June 13, 2008. About PharmAthene, Inc. PharmAthene's (Amex: pip ) mission is to be the premier company worldwide specializing in the develo...

PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008

... ANNAPOLIS, Md., May 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...pproximately June 13, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed in March 2001 with a mission to become the premier company wor...

PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit

...IS, Md., April 2, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...e against anthrax threats." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports Year-End 2007 Financial Results

...NNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...proximately April 30, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program

...NAPOLIS, Md., March 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...hich are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008

...NAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica...ys, or until April 30, 2008. About PharmAthene, Inc PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene to Delay Release of Full Year 2007 Financial Results

...NNAPOLIS, Md., March 20 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...on announced earlier today. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia

...e website. The webcast will be available for 30 days, or until approximately Thursday, April 17, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference

...NAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008

...sified as either G-agents (sarin, soman, tabun) or V-agents (VX), both of which are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations

...aduate of the University of Pittsburgh where she received a Ph.D. in Microbiology/Biological Sciences. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the BIO CEO & Investor Conference 2008

...ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA

...NNAPOLIS, Md., Jan. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... the treatment of smallpox. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services

...NNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company specializing in the development and commercializati...ecuted agreement is received. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its Allies...

Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court

... ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, announced today that proceeding...

Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.

... ANNAPOLIS, Md., Aug. 17 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) announced today that a hearing has been scheduled by the Delaware Court of Chancery for 2:00 p.m. on Monday, August 27, 2007, in an action filed by ...

Technology changing for better, Coburn says

... Madison, Wis. - pip Coburn offers a different framework for selling products to what he calls, in a tongue-in-cheek manner, "real humans." And given his forecasting credi...
Other Tags
(Date:8/22/2014)... 2015, American consumers will finally be able to purchase ... touted as zero-emissions vehicles, most of the cars will ... fuel that contributes to global warming. , Now scientists ... that uses an ordinary AAA battery to produce hydrogen ... current through two electrodes that split liquid water into ...
(Date:8/21/2014)... 21, 2014 Nxt-ID, Inc. (OTCQB: NXTD), a ... market, announced today that its shares of common stock ... issued in its proposed underwritten public offering of common ... The Nasdaq Capital Market, subject to closing of its ... warrants, and will trade under the symbol "NXTD" and ...
(Date:8/21/2014)... at improving the food intake, health and quality of ... among three projects at the University of Waterloo receiving ... Institutes of Health Research (CIHR). , Professor Heather ... Waterloo, and a Schlegel research chair in nutrition and ... why many Canadians living in long-term care homes are ...
Breaking Biology News(10 mins):Stanford scientists develop a water splitter that runs on an ordinary AAA battery 2Stanford scientists develop a water splitter that runs on an ordinary AAA battery 3Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2
(Date:8/22/2014)... Lake Worth, FL (PRWEB) August 22, 2014 ... alcohol addiction treatment facility in Lantana, FL, recently ... or those just looking for information can now ... , Millennium’s new website just went live at ... to know about the facility can be found ...
(Date:8/22/2014)... DENVER For the first time an oncogenic somatic ... during transfection) protein has been identified in small cell ... mutation within SCLC cell lines produced increased intracellular signaling ... form of lung cancer representing 15% of all lung ... representing 85% of lung cancer, has been extensively examined ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
(Date:8/22/2014)... 2014 The improved access to antiretroviral ... the developing world, has led to the decline in ... deaths due to AIDS globally. However, despite the fact ... new patients becoming affected by the virus is on ... by all related organisations and stakeholders, by 2015, significant ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 A national leader ... into new offices with room to grow. , Headquarters for ... to a 60,000-square-foot office building at 8516 N.W. Expressway in ... named one of the Oklahoma’s best places to work by ... The company has hired 120 in the past two years, ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2
Other Contents